A new study published in May by the American Diabetes Association® in collaboration with dQ&A shows that growing numbers of people with diabetes have...
The Food and Drug Administration on Friday approved oral dapagliflozin (Farxiga) tablets to slow the progression of chronic kidney disease in adults with and...